Search Results - "Grypiotis, P."

Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatement with infliximab by Hoxha, A., Ruffatti, A., Grypiotis, P., Podswiadek, M., Botsios, C., Fiocco, U., Punzi, L., Todesco, S.

“…Objective: We evaluated the induction and clinical significance of ANA, anti-dsDNA and anti-ENA during infliximab therapy in patients with Rheumatoid Arthritis…”
Get full text

Clinical significance of fluoroscopic patterns specific for the mitotic spindle in patients with reumatic diseases by Grypiotis, P., Ruffatti, A., Tonello, M., Winzler, C., Radu, C., Zampieri, S., Favaro, M., Calligaro, A., Todesco, S.

“…Objective: we proposed to determine the clinical significance of anti-NuMA and anti-HsEg5 antibodies in a group of patients affected with rheumatic diseases…”
Get full text

Sensibility and specificity for pregnancy morbidity of anti-b2-glycoprotein I antibodies in antiphospholipid syndrome by Tonello, M., Ruffatti, A., Favaro, M., Del Ross, T., Zamboni, D., Grypiotis, P., Cavazzana, A., Ciprian, M., Todesco, S.

“…Objective: This study aimed to evaluate the sensitivity and specificity of the anti-b2-glycoprotein I antibodies for pregnancy morbidity in the antiphosoplipid…”
Get full text

Prevalence and clinical significance of cathepsin G antibodies in systemic sclerosis by Grypiotis, P, Ruffatti, A, Cozzi, F, Sinico, R A, Tonello, M, Radice, A, Favaro, M, Todesco, S

“…To evaluate the prevalence and clinical significance of cathepsin G antibodies in patients affected with systemic sclerosis (SSc, scleroderma). 115 patients…”
Get full text

Autoantibodies to bactericidal/permeability-increasing protein and cathepsin G in systemic sclerosis by Grypiotis, Panagiotis, Cozzi, Franco, Ruffatti, Amelia

Get full text

Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis by RUFFATTI, Amelia, SINICO, Renato Alberto, RADICE, Antonella, OSSI, Elena, COZZI, Franco, TONELLO, Marta, GRYPIOTIS, Panagiotis, TODESCO, Silvano

“…OBJECTIVE: We evaluated the prevalence and clinical significance of proteinase 3 (PR3-) and myeloperoxidase (MPO-) antineutrophil cytoplasmic antibodies (ANCA)…”
Get full text

Use of a new silica clotting time for diagnosing lupus anticoagulant in patients who meet the clinical criteria for antiphospholipid syndrome by Grypiotis, Panagiotis, Ruffatti, Amelia, Pengo, Vittorio, Tonello, Marta, Biasiolo, Alessandra, Zamboni, Daniela, Cavazzana, Anna, Todesco, Silvano

“…The silica clotting time (SCT) is a phospholipid‐dependent coagulation assay used for the laboratory diagnosis of lupus anticoagulant (LA) antibodies. The…”
Get full text

Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatment with infliximab by Hoxha, A, Ruffatti, A, Grypiotis, P, Podswiadek, M, Botsios, C, Fiocco, U, Punzi, L, Todesco, S

“…We evaluated the induction and clinical significance of ANA, anti-dsDNA and anti-ENA during infliximab therapy in patients with Rheumatoid Arthritis (RA) or…”
Get full text

Sensibility and specificity for pregnancy morbidity of anti-β2-glycoprotein I antibodies in antiphospholipid syndrome by Tonello, M, Ruffatti, A, Favaro, M, Del Ross, T, Zamboni, D, Grypiotis, P, Cavazzana, A, Ciprian, M, Todesco, S

“…This study aimed to evaluate the sensitivity and specificity of the anti-β2-glycoprotein I (GPI) antibodies for pregnancy morbidity in the antiphosoplipid…”
Get full text

Clinical significance of fluoroscopic patterns specific for the mitotic spindle in patients with rheumatic diseases by Grypiotis, P, Ruffatti, A, Tonello, M, Winzler, C, Radu, C, Zampieri, S, Favaro, M, Calligaro, A, Todesco, S

“…To determine the clinical significance of anti-NuMA and anti-HsEg5 antibodies in a group of patients affected with rheumatic diseases. Indirect…”
Get full text